Variant report

Variant	esv3393959
Chromosome Location	chr15:92935948-92939196
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:75)
CpG islands
(count:1037)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:75 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr15:92937395-92937544	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr15:92936719-92936840	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr15:92937871-92938056	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD1	chr15:92937189-92937501	H1-hESC	embryonic stem cell:	n/a	chr15:92937250-92937260
5	CHD1	chr15:92936791-92936952	H1-hESC	embryonic stem cell:	n/a	n/a
6	CHD2	chr15:92936414-92936773	H1-hESC	embryonic stem cell:	n/a	n/a
7	CREB1	chr15:92936565-92937698	H1-hESC	embryonic stem cell:	n/a	n/a
8	CREB1	chr15:92936690-92937292	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTBP2	chr15:92936285-92937466	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTBP2	chr15:92937744-92938725	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTCF	chr15:92936700-92936850	HRE	kidney:	n/a	n/a
12	CTCF	chr15:92937620-92937770	AG04449	skin:	n/a	n/a
13	CTCF	chr15:92936720-92936870	SK-N-SH_RA	brain:	n/a	n/a
14	CTCF	chr15:92938060-92938210	WERI-Rb-1	eye:	n/a	chr15:92938122-92938135
15	CTCF	chr15:92938140-92938290	SK-N-SH_RA	brain:	n/a	n/a
16	CTCF	chr15:92938000-92938150	GM12874	blood:	n/a	chr15:92938122-92938135
17	CTCF	chr15:92939140-92939290	GM12868	blood:	n/a	n/a
18	CTCF	chr15:92937640-92937790	WERI-Rb-1	eye:	n/a	n/a
19	CTCF	chr15:92937620-92937770	WERI-Rb-1	eye:	n/a	n/a
20	CTCF	chr15:92938220-92938370	HAc	cerebellar:	n/a	n/a
21	E2F6	chr15:92937227-92938583	H1-hESC	embryonic stem cell:	n/a	chr15:92937818-92937827 chr15:92938157-92938174 chr15:92937577-92937586 chr15:92937789-92937804 chr15:92938157-92938174
22	E2F6	chr15:92937655-92938625	H1-hESC	embryonic stem cell:	n/a	chr15:92937818-92937827 chr15:92938157-92938174 chr15:92937789-92937804 chr15:92938157-92938174
23	GABPA	chr15:92937054-92937453	H1-hESC	embryonic stem cell:	n/a	chr15:92937205-92937214 chr15:92937198-92937207
24	GABPA	chr15:92937065-92937335	H1-hESC	embryonic stem cell:	n/a	chr15:92937205-92937214 chr15:92937198-92937207
25	GABPA	chr15:92936744-92937020	H1-hESC	embryonic stem cell:	n/a	chr15:92936906-92936915
26	GABPA	chr15:92937948-92938480	H1-hESC	embryonic stem cell:	n/a	n/a
27	GATA2	chr15:92936237-92936823	SH-SY5Y	brain:	n/a	n/a
28	GTF2F1	chr15:92937988-92938126	H1-hESC	embryonic stem cell:	n/a	n/a
29	GTF2F1	chr15:92936770-92936957	H1-hESC	embryonic stem cell:	n/a	n/a
30	JUND	chr15:92936752-92936906	H1-hESC	embryonic stem cell:	n/a	n/a
31	KAP1	chr15:92937219-92937419	HEK293	kidney:	n/a	n/a
32	MAX	chr15:92936603-92937440	H1-hESC	embryonic stem cell:	n/a	chr15:92936907-92936917
33	MAX	chr15:92936824-92937469	ECC-1	luminal epithelium:	n/a	chr15:92936907-92936917
34	MAX	chr15:92936463-92938759	H1-hESC	embryonic stem cell:	n/a	chr15:92938512-92938521 chr15:92937667-92937677 chr15:92936907-92936917 chr15:92938011-92938021 chr15:92937571-92937581
35	MAX	chr15:92936496-92938099	H1-hESC	embryonic stem cell:	n/a	chr15:92937667-92937677 chr15:92936907-92936917 chr15:92938011-92938021 chr15:92937571-92937581
36	MAX	chr15:92938170-92938733	H1-hESC	embryonic stem cell:	n/a	chr15:92938512-92938521
37	MXI1	chr15:92936837-92937485	H1-hESC	embryonic stem cell:	n/a	n/a
38	MXI1	chr15:92936549-92939002	SK-N-SH	brain:	n/a	n/a
39	MYC	chr15:92936832-92937386	H1-hESC	embryonic stem cell:	n/a	chr15:92936907-92936917
40	POLR2A	chr15:92937002-92937261	H1-hESC	embryonic stem cell:	n/a	n/a
41	POLR2A	chr15:92936281-92938278	H1-neurons	neurons:	n/a	n/a
42	POLR2A	chr15:92938809-92938927	H1-hESC	embryonic stem cell:	n/a	n/a
43	POLR2A	chr15:92936218-92938920	H1-neurons	neurons:	n/a	n/a
44	POLR2A	chr15:92937291-92937491	H1-hESC	embryonic stem cell:	n/a	n/a
45	POLR2A	chr15:92936633-92937252	H1-hESC	embryonic stem cell:	n/a	n/a
46	POLR2A	chr15:92936271-92938347	H1-hESC	embryonic stem cell:	n/a	n/a
47	POLR2A	chr15:92937047-92937175	H1-hESC	embryonic stem cell:	n/a	n/a
48	POLR2A	chr15:92938327-92938633	H1-hESC	embryonic stem cell:	n/a	n/a
49	POLR2A	chr15:92936762-92938175	H1-hESC	embryonic stem cell:	n/a	n/a
50	POLR2A	chr15:92936799-92936978	H1-hESC	embryonic stem cell:	n/a	n/a

(count:1037 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:92938015-92938065	GM12878	blood:	n/a
2	chr15:92939006-92939056	AG04450	lung:	fetal
3	chr15:92938502-92938552	SAEC	small airway:	n/a
4	chr15:92938576-92938626	U87	brain:	n/a
5	chr15:92938295-92938345	BJ	skin:	n/a
6	chr15:92937285-92937335	SAEC	small airway:	n/a
7	chr15:92938179-92938229	HEEpiC	esophagus:	n/a
8	chr15:92936232-92936282	LNCaP	prostate:	n/a
9	chr15:92936818-92936868	LNCaP	prostate:	n/a
10	chr15:92938502-92938552	H1-hESC	embryonic stem cell:	embryo
11	chr15:92936678-92936728	HEK293	kidney:	embryo
12	chr15:92936232-92936282	AG09309	skin:	n/a
13	chr15:92936678-92936728	Hepatocyte	liver:	n/a
14	chr15:92938179-92938229	HEK293	kidney:	embryo
15	chr15:92938015-92938065	ECC-1	luminal epithelium:	n/a
16	chr15:92938179-92938229	Jurkat	blood:	n/a
17	chr15:92936818-92936868	AG09319	gingival:	n/a
18	chr15:92938502-92938552	SK-N-SH	brain:	n/a
19	chr15:92937992-92938042	RPTEC	kidney:	n/a
20	chr15:92938502-92938552	SK-N-MC	brain:	n/a
21	chr15:92938295-92938345	GM12878	blood:	n/a
22	chr15:92937735-92937785	ECC-1	luminal epithelium:	n/a
23	chr15:92938576-92938626	SAEC	small airway:	n/a
24	chr15:92937285-92937335	AG04450	lung:	fetal
25	chr15:92938576-92938626	GM12892	blood:	n/a
26	chr15:92936818-92936868	HPAEpiC	pulmonary alveolar:	n/a
27	chr15:92936818-92936868	AoSMC	blood vessel:	n/a
28	chr15:92936678-92936728	Caco-2	colon:	n/a
29	chr15:92937992-92938042	PrEC	prostate:	n/a
30	chr15:92939006-92939056	HPAEpiC	pulmonary alveolar:	n/a
31	chr15:92937360-92937410	HPAEpiC	pulmonary alveolar:	n/a
32	chr15:92938015-92938065	NHDF-neo	bronchial:	n/a
33	chr15:92937992-92938042	Caco-2	colon:	n/a
34	chr15:92938295-92938345	RPTEC	kidney:	n/a
35	chr15:92938015-92938065	HNPCEpiC	eye:	n/a
36	chr15:92937735-92937785	AG10803	skin:	n/a
37	chr15:92939006-92939056	HCF	heart:	n/a
38	chr15:92938179-92938229	HIPEpiC	eye:	n/a
39	chr15:92936856-92936906	Caco-2	colon:	n/a
40	chr15:92937285-92937335	Caco-2	colon:	n/a
41	chr15:92938179-92938229	NH-A	brain:	n/a
42	chr15:92937735-92937785	HCM	heart:	n/a
43	chr15:92938295-92938345	HL-60	blood:	n/a
44	chr15:92937285-92937335	HL-60	blood:	n/a
45	chr15:92936465-92936515	NH-A	brain:	n/a
46	chr15:92939006-92939056	CMK	blood:	n/a
47	chr15:92938179-92938229	BE2_C	brain:	n/a
48	chr15:92937285-92937335	HCM	heart:	n/a
49	chr15:92938576-92938626	GM19239	blood:	n/a
50	chr15:92938502-92938552	HepG2	liver:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:92938506..92940378-chr15:92942653..92944653,2	MCF-7	breast:
2	chr15:92937393..92940056-chr15:92940490..92942465,3	K562	blood:
3	chr15:92927559..92930317-chr15:92934349..92936037,2	MCF-7	breast:

No data

Variant related genes	Relation type
ST8SIA2	TF binding region
ST8SIA2	CpG island

Extended variants
information (count: 117 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:117 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs573967470	chr15:92935989-92935990	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs570402569	chr15:92936002-92936003	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs545504183	chr15:92936003-92936004	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs35422826	chr15:92936009-92936010	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs372324647	chr15:92936010-92936011	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs116700538	chr15:92936012-92936013	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs541255439	chr15:92936089-92936090	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs192565050	chr15:92936108-92936109	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs3759916	chr15:92936169-92936170	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs561854995	chr15:92936221-92936222	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs185047835	chr15:92936237-92936238	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs150882587	chr15:92936297-92936298	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs541468318	chr15:92936309-92936310	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs564445219	chr15:92936333-92936334	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs3759915	chr15:92936388-92936389	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs563761184	chr15:92936413-92936414	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs3759914	chr15:92936444-92936445	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs569742224	chr15:92936479-92936480	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs74029013	chr15:92936497-92936498	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs115434161	chr15:92936554-92936555	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs79668601	chr15:92936584-92936585	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs372415400	chr15:92936620-92936621	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs8037519	chr15:92936624-92936625	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs1872925	chr15:92936695-92936696	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs575871478	chr15:92936742-92936743	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs138393846	chr15:92936774-92936775	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs570469728	chr15:92936776-92936777	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs79315102	chr15:92936804-92936805	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs556175761	chr15:92936826-92936827	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs568389017	chr15:92936955-92936956	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs576154526	chr15:92936966-92936967	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs535705960	chr15:92937066-92937067	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs368854589	chr15:92937079-92937080	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs555701735	chr15:92937092-92937093	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs142883061	chr15:92937137-92937138	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs540882925	chr15:92937218-92937219	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs188927412	chr15:92937240-92937241	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs543941107	chr15:92937244-92937245	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs376346311	chr15:92937265-92937266	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs3743365	chr15:92937268-92937269	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs3743364	chr15:92937276-92937277	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs370916519	chr15:92937309-92937310	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs559644711	chr15:92937321-92937322	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs528653957	chr15:92937334-92937335	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs551668161	chr15:92937342-92937343	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs374608010	chr15:92937345-92937346	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs372146416	chr15:92937357-92937358	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs539787829	chr15:92937366-92937367	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs140295425	chr15:92937379-92937380	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs565734813	chr15:92937412-92937413	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Wilms tumour	21544195	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Cancer	16751803	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	16864856	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Sudden cardiac death	19188705	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Epilepsy	19486360	CNVD
Acute myeloid leukemia	17237825	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Ovarian cancer	21720365	CNVD
Developmental delay	21147756	CNVD
Hepatocellular carcinoma	16750200	CNVD
Central neurocytomas	17123091	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Myelofibrosis	22110671	CNVD
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	21339820	CNVD

Chromatin state (count:330 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:92935000-92936400	Enhancers	Fetal Brain Male	brain
2	chr15:92935200-92936400	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
3	chr15:92935200-92936400	Bivalent Enhancer	Fetal Thymus	thymus
4	chr15:92935400-92936400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
5	chr15:92935400-92936400	Bivalent Enhancer	Fetal Muscle Leg	muscle
6	chr15:92935400-92936600	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
7	chr15:92935400-92936600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
8	chr15:92935400-92936600	Flanking Active TSS	Brain Germinal Matrix	brain
9	chr15:92935400-92938400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
10	chr15:92935400-92938800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
11	chr15:92935600-92936000	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr15:92935600-92936200	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
13	chr15:92935600-92936200	Enhancers	Breast Myoepithelial Primary Cells	Breast
14	chr15:92935600-92936400	Bivalent Enhancer	Fetal Stomach	stomach
15	chr15:92935600-92936600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
16	chr15:92935600-92936600	Flanking Active TSS	Fetal Brain Female	brain
17	chr15:92935600-92936600	Bivalent Enhancer	NHDF-Ad	bronchial
18	chr15:92935600-92936800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
19	chr15:92935800-92936000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
20	chr15:92935800-92936000	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
21	chr15:92935800-92936000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
22	chr15:92935800-92936000	Bivalent Enhancer	Esophagus	oesophagus
23	chr15:92935800-92936200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
24	chr15:92935800-92936400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr15:92935800-92936400	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
26	chr15:92935800-92936400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
27	chr15:92935800-92936800	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
28	chr15:92935800-92936800	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr15:92935800-92938800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
30	chr15:92936000-92936200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
31	chr15:92936000-92936200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
32	chr15:92936000-92936200	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
33	chr15:92936000-92936200	Bivalent Enhancer	Fetal Heart	heart
34	chr15:92936000-92936400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
35	chr15:92936000-92936400	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr15:92936000-92936400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
37	chr15:92936000-92936400	Bivalent Enhancer	Fetal Lung	lung
38	chr15:92936000-92936400	Bivalent Enhancer	Stomach Smooth Muscle	stomach
39	chr15:92936000-92936400	Enhancers	HSMMtube	muscle
40	chr15:92936200-92936400	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr15:92936200-92936400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
42	chr15:92936200-92936400	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
43	chr15:92936200-92936400	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
44	chr15:92936200-92936600	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
45	chr15:92936200-92936600	Flanking Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
46	chr15:92936200-92936600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr15:92936200-92936600	Bivalent Enhancer	A549	lung
48	chr15:92936200-92936800	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
49	chr15:92936200-92936800	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr15:92936200-92936800	Enhancers	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links